Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M W Savage

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Postgraduate Medical Journal|September 10, 2004
Endocrine emergenciesM W Savage, P M Mah, A P Weetman, et al.
Clinical Science (London, England : 1979)|October 24, 1997
Impaired insulin-induced attenuation of noradrenaline-mediated vasoconstriction in insulin-resistant obese Zucker ratsA B Walker, J Dores, R E Buckingham, et al.
British Journal of Haematology|December 1, 1990
High dose intravenous methotrexate and reversible focal neurological deficitM W Savage, C P Raguram, S Rogers, et al.
Postgraduate Medical Journal|June 1, 1992
Acute intermittent porphyria treated by testosterone implantM W Savage, P Reed, S L Orrman-Rossiter, et al.
Journal of Diabetes and Its Complications|June 9, 1998
Lack of relationship between sympathetic nervous system activity, measured by two circulating markers, and blood pressure in diabetic and nondiabetic subjectsE Carstensen, M J Sampson, M W Savage, et al.
Clinical Endocrinology|July 1, 1995
Effects of quinagolide (CV 205-502), a selective D2-agonist, on vascular reactivity in patients with a prolactin-secreting adenomaC W Bodmer, S L Atkin, M W Savage, et al.
HIV Medicine|September 15, 2005
The development of hypophosphataemic osteomalacia with myopathy in two patients with HIV infection receiving tenofovir therapyM J Parsonage, E G L Wilkins, N Snowden, et al.
European Journal of Clinical Investigation|May 1, 1994
Smoking attenuates the vasoconstrictor response to noradrenaline in type I diabetic patients and normal subjects: possible relevance to diabetic nephropathyC W Bodmer, D T Valentine, E A Masson, et al.
Diabetologia|October 1, 1994
Asymptomatic peripheral nerve dysfunction and vascular reactivity in IDDM patients with and without microalbuminuriaC W Bodmer, E A Masson, M W Savage, et al.
European Journal of Clinical Investigation|December 1, 1995
Vascular reactivity to noradrenaline and neuropeptide Y in the streptozotocin-induced diabetic ratM W Savage, C W Bodmer, A B Walker, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Postgraduate Medical Journal|September 10, 2004
Endocrine emergenciesM W Savage, P M Mah, A P Weetman, et al.
Clinical Science (London, England : 1979)|October 24, 1997
Impaired insulin-induced attenuation of noradrenaline-mediated vasoconstriction in insulin-resistant obese Zucker ratsA B Walker, J Dores, R E Buckingham, et al.
British Journal of Haematology|December 1, 1990
High dose intravenous methotrexate and reversible focal neurological deficitM W Savage, C P Raguram, S Rogers, et al.
Postgraduate Medical Journal|June 1, 1992
Acute intermittent porphyria treated by testosterone implantM W Savage, P Reed, S L Orrman-Rossiter, et al.
Journal of Diabetes and Its Complications|June 9, 1998
Lack of relationship between sympathetic nervous system activity, measured by two circulating markers, and blood pressure in diabetic and nondiabetic subjectsE Carstensen, M J Sampson, M W Savage, et al.
Clinical Endocrinology|July 1, 1995
Effects of quinagolide (CV 205-502), a selective D2-agonist, on vascular reactivity in patients with a prolactin-secreting adenomaC W Bodmer, S L Atkin, M W Savage, et al.
HIV Medicine|September 15, 2005
The development of hypophosphataemic osteomalacia with myopathy in two patients with HIV infection receiving tenofovir therapyM J Parsonage, E G L Wilkins, N Snowden, et al.
European Journal of Clinical Investigation|May 1, 1994
Smoking attenuates the vasoconstrictor response to noradrenaline in type I diabetic patients and normal subjects: possible relevance to diabetic nephropathyC W Bodmer, D T Valentine, E A Masson, et al.
Diabetologia|October 1, 1994
Asymptomatic peripheral nerve dysfunction and vascular reactivity in IDDM patients with and without microalbuminuriaC W Bodmer, E A Masson, M W Savage, et al.
European Journal of Clinical Investigation|December 1, 1995
Vascular reactivity to noradrenaline and neuropeptide Y in the streptozotocin-induced diabetic ratM W Savage, C W Bodmer, A B Walker, et al.
Pageof 3